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Epstein-Barr  virus  (EBV) 1 is  a  herpes  virus that  can  infect  human  B  cells. This 
virus has been shown to be the causative agent in infectious mononucleosis (I) and to 
be associated with several other disorders including African Burkitt's lymphoma (2), 
nasopharyngeal  carcinoma  (3),  and  certain  cases  of  acquired  hypogammaglobu- 
linemia (4). Many if not all human B  cells have receptors for EBV that appear to be 
necessary for infection by the virus (5-7). B cells so infected may be induced to secrete 
immunoglobulin  (Ig)  (8)  and may become transformed into long-term cell lines  (9). 
Ig production  induced by the B95-8  strain of EBV  does not  require the presence of 
either T  cells or monocytes (10,  11), and this strain has found wide usage as a  tool to 
study the functional capabilities of human B cells. All major classes of Ig are secreted 
by B95-8-stimulated cultures of human  B  cells, and  the relative proportion of these 
classes is generally not affected by the addition of T  cells (12). 
Recent in vitro studies (13) have demonstrated that whereas most if not all human 
B cells have receptors for EBV, only a  proportion of these cells can be transformed by 
the virus. It has in addition been  inferred that  only a  small subset of human  B  cells 
are induced to secrete Ig by infection with EBV  (8,  14). In the present experiments, 
we have used Poisson analysis of limiting dilution cultures to determine the precursor 
frequencies of human peripheral blood B cells that can be activated by EBV to secrete 
IgG or IgM in short-term culture. We have also demonstrated that the precursor cells 
are induced by EBV  to secrete  IgG or IgM,  but  not  both  classes of Ig.  Finally, we 
have  determined that  the activation of B  cells to Ig production  is consistent with  a 
"one-hit"  model;  that  is,  infection  by one  virion  is sufficient  to  induce  a  B  cell to 
produce Ig in short-term culture. 
Materials  and  Methods 
Preparations  of Virus.  Three  preparations of the  B95-8  strain of EBV  were used  in  these 
experiments. Preparations 1 and 2 were obtained by sterile filtration of the supernatant of the 
B95-8 marmoset cell line through a 45-/~m filter (Nalge Co., Nalgene Labware Div., Rochester, 
NY); these preparations had 104 and 106 umbilical cord-transforming units per ml, respectively, 
as determined by conventional technique (15). Preparation 3 was obtained in a similar fashion, 
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except that  the supernatant  was first concentrated  100-fold by uhracentrifugation  at  120,000 
g for 60 rain; this preparation  had > 109 umbilical cord transforming units per ml. Preparation 
1 was used in studies of the viral requirements for B cell activation, and preparations  2 and 3 
were used in B cell precursor frequency determinations. 
Lymphocyte Preparation and Culture Conditions.  Heparinized  peripheral  venous blood was ob- 
tained  from  healthy  adult  donors  between  the  ages  of  25  and  40  yr.  Peripheral  blood 
mononuclear cells were obtained by FicolI-Hypaque centrifugation  (16)  and partially depleted 
of cytophilic Ig by incubation for 1 h at 37°C in RPMI  1640 medium supplemented with  100 
U/ml penicillin, 100/lg/ml streptomycin, and 5% fetal calf serum (FCS) (all from Grand Island 
Biological Co.,  Grand  Island,  NY).  B  and  T  cell-enriched  populations  were prepared  using 
columns  of  rabbit  anti-human-F(ab')2  antibody  bound  to  Sephadex  G200  as  previously 
described (17).  The B cell-enriched populations so prepared contained <2% T  cells as detected 
by E  rosetting,  and  the T  cell-enriched populations  contained  <2%  sIg  + cells as  determined 
with a  fluorescein-conjugated goat anti-human  Ig antisera  (N. L. Cappel  Laboratories,  Coch- 
ranville, PA) (18).  The B cell-enriched populations so prepared contained 50  65% B cells (mean 
60%), as determined by the criteria of: (a) staining with fluorescein-conjugated anti-human  Ig, 
and  (b)  failure  to  ingest  latex  beads  (Sigma  Chemical  Co.,  St.  Louis,  MO).  In  experiments 
undertaken  to determine the frequency of infectious EBV particles, the B cell population was 
further purified by E-rosette depletion as previously described (12).  These B and T cell-enriched 
populations  were further depleted of cytophilic Ig by two centrifugations  through  FCS  (18). 
The cells were resuspended  in media and counted with trypan  blue. 
B  cell precursor  frequencies for cells producing  IgG or IgM were determined  by  limiting 
dilution analysis of multiple microcultures. Replicate cultures of 1 X  l0  s T  cells irradiated with 
1,200  rad and varying numbers of B cells were established  in 96-well flat-bottomed microtiter 
plates  (Costar,  Data  Packaging,  Cambridge,  MA)  in  a  final  volume  of 0.25  ml  of media 
consisting of RPMI  1640  supplemented  with  50  U/ml  penicillin,  50 ~g/ml  streptomycin,  4 
mM L-glutamine (Grand Island Biological Co.), and 10% FCS (Reheis, Armour Pharmaceutical 
Co., Kankakee,  IL).  Irradiation  of the T  cell-enriched population  served the dual  purpose  of 
preventing Ig secretion by any contaminating B cells in this preparation and of eliminating the 
effect of suppressor T  cells (19-21). At least 24 replicate cultures were established for each dose 
of B  cells;  in addition,  at  least  24 control  wells were established  with  no added  B  cells. The 
cultures  were stimulated  with  preparation  2  of EBV  at  a  final  dilution  of  1:5  or pokeweed 
mitogen (PWM)  (Grand  Island Biological Co.) at a  final dilution of 1:100. The cultures were 
incubated at 37°C in a humidified atmosphere supplemented with 5% CO2 for 14 d. The plates 
were  then  centrifuged  at  450 g  for  10  min,  the  supernatants  were  harvested,  and  the  latter 
transferred to fresh microtiter plates and stored at 4°C. Assays for IgG and IgM were performed 
within 2 wk of harvest. 
In certain experiments, macrocultures were simultaneously established  in  16-ram well diam 
cluster tissue culture plates (Costar 3524). These macrocultures contained  106 irradiated T  cells 
(1,200  rad)  and  t0  s  B  cells  in  a  total  volume  of 2.5  ml  of the  same  media  used  in  the 
microcultures.  These  macrocultures  were  likewise stimulated  with  the  B95-8  strain  of EBV 
(final  dilution  1:5),  cultured  for  14  d,  harvested,  and  the supernatants  stored  at  4°C  until 
assayed. 
Enzyme-linked hnmunosorbent Assay (ELISA) for Total IgG and IgM.  The total IgG and IgM in 
the culture  supernatants  was  determined  by a  "sandwich"  ELISA similar to that  previously 
described  (17,  18). To  measure  total  IgG,  wells  of flat-bottomed  ELISA  plates  (1-223-29; 
Dynatech  Corp.,  Alexandria,  VA)  were coated  overnight with  150  /L1 of a  1:600  dilution  of 
affinity-purified goat anti-human  IgG antibody in pH 9.6 carbonate buffer, washed three times 
with  phosphate-buffered  saline  (pH  7.2)  containing 0.05%  Tween  20  (Sigma Chemical  Co.) 
and  0.02%  sodium  azide  (PBS-Tween)  using a  semiautomated  washer  (Miniwash;  Dynatech 
Corp.),  and  filled with  100-bd aliquots of the culture supernatants  diluted  l:l  in  PBS-Tween 
with 1% FCS. Each plate also contained six serial twofold dilutions of an IgG standard  ranging 
between  100  and  3.13  ng/ml.  After a  2-h  incubation  at  room  temperature  in  a  humidified 
atmosphere  enriched  with  5%  CO2,  the wells were washed  as  above and  incubated  at  room 
temperature  with  100  btl  of a  1:400  dilution  of goat  anti-human  IgG conjugated  to alkaline 
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developed for 2 h  with  1 mg/ml p-nitrophenol phosphate  (Sigma Chemical Co.) in diethanol- 
amine buffer  (pH  9.8),  and the optical density at 405  nm was read using a  Muhiskan  (Flow 
Laboratories, Rockville, MD). 
Total IgM was determined in a  similar manner as previously described (17).  In this case, a 
rabbit  anti-human  IgM was  used  to coat  the substrate  plates,  and  an  alkaline-phosphatase- 
conjugated rabbit anti-human  IgM used to detect bound IgM Ig. When this assay was used to 
quantitatively  measure  IgM  produced  by  the  macrocultures  or  pooled  microcultures,  each 
sample was assayed at several dilutions. Purified IgA and IgM myeloma proteins and purified 
IgG were used to test the specificity of the assays;  the preparation of these purified Ig has been 
previously described (22). The lower limit of sensitivity of these assays was ~3 ng/ml of Ig. 
Determination of B Cell Precursor  Frequencies  for IgG and IgM Production.  Poisson analysis of these 
limiting dilution microcultures was used to determine the B cell precursor frequencies for IgG 
and IgM production. Ifa cell type being titrated in such cultures is randomly and independently 
distributed among a number of wells, then the number of precursors cells per welt should follow 
the Poisson  distribution  (see ref. 23 for a  discussion of the derivation and application of this 
formula:) 
e -u 
Fi -----  ."77-. "u  i, 
11 
where Fi is the expected fraction of wells with i precursors when there are a mean ofu precursors 
per well. If all the wells with one or more precursors are scored as positive, then Fo, the expected 
fraction of negative wells, is: Fo -- e -u. The mean number of precursors per well (u)  is equal to 
the number  of added  B  cells  (N)  times  the precursor  frequency f,  and  thus,  the  number  of 
added  B  cells should  be proportional  to -ln(Fo).  When  there  is a  mean of one precursor per 
well (u =  1), then Fo =  e -I -- 0.368.  At this point, the precursor frequency (f) should be 1/N. 
In these experiments, the IgG and/or IgM in the microculture supernatants were determined 
by ELISA. Those wells with  more IgG or IgM than  the arithmetic  mean  plus  2  SD of that 
found in the control wells (no B cells) were scored as positive for that  isotype, and the fraction 
of negative wells for IgG and/or for IgM was calculated for each dose of added B cells. Most of 
the wells scored  as  "positive" in these experiments  far exceeded the 2-SD cutoff. The actual 
number of added  B  cells was considered  to be 60% of the added  B  cell-enriched populations 
based  on  the  mean  determination  of the  frequency  of surface  Ig-positive,  latex  ingestion- 
negative cells in these populations  as described above. The B  cell precursor frequency (f)  for 
IgG  and  IgM  production  that  best  fits  the  experimental  data  to  the  formula  above  was 
estimated  using  the  minimum  X  2 method  described  by  Taswell  (24).  This  calculation  was 
performed using an iterative program written for a Wang 2200 computer (Wang Laboratories, 
Lowell, MA). Only those experiments where both P >  0.05  (goodness of fit test) and where the 
frequency  determined  by  minimum  chi  square  was  within  15%  of that  determined  by  the 
maximum likelihood method were accepted as valid (24); most experiments far exceeded these 
criteria.  In some experiments, the number of wells that  were scored as positive for IgG only, 
IgM only, neither, or both was determined, and the independence of IgG and IgM production 
tested by X  2 analysis with continuity correction of the resulting 2 ×  2 contingency table (25). 
Determination of the Frequency of Stimulating  Viral Particles.  Because EBV is particulate,  it was 
hypothesized that Poisson analysis could also be used to test whether or not activation of B cells 
by EBV followed a  one-hit model (i.e., one infecting viral particle is sufficient to stimulate Ig 
production)  and if so, to determine the frequency of stimulating viral particles in preparations 
of EBV. To this end, multiple replicate microcultures of 105 B cells ]prepared  by anti-F(ab')2 
column plus E-rosette depletion] were stimulated with successive dilutions of preparation  I of 
EBV; this number of B cells ensured that  the precursors for IgM or IgG would not be limiting 
(see below). The same lot of FCS that  the productive B95-8 marmoset  line was grown in was 
used  in  these  experiments  to  prepare  the  culture  medium.  As  negative  controls,  multiple 
replicate wells were established without any added EBV. After 14 d, the cultures were harvested 
as above and  the supernatants  assayed  for IgM and/or  IgG by ELISA. The wells with  more 
IgM than the mean +  2 SD of that in the control wells (no added EBV) were scored as positive, 
and the fraction of positive wells was calculated for each dilution of virus. Similar calculations 
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Analysis of the number of EBV virions required to activate a  B  cell to produce either IgM 
or IgG was performed using a strategy modified from that of Parker (26). If pi is the probability 
that i viral particles will infect a  given B  cell precursor in a  culture containing N  potential B 
cell  precursors and a  given dilution of the B95-8 supernatant, then, according to the Poisson 
distribution: 
e-U 
pi  =  -~-., -ui, 
where u  is the mean number of infecting viral particles per precursor B cell. It is assumed that 
u  is proportional to the concentration of the B95-8 supernatant. Thus, the probability that a 
given cell will not be infected by any virions is: p0 =  e -u, and the probability that none of the 
cells will be infected is: P_ =  p0  r~ =  e -uN.  If we hypothesize that infection of a  precursor B cell 
by one EBV virion is sufficient to induce it to produce Ig (one-hit model), then the probability 
of there being at least one B cell producing Ig in a well containing N  precursors is: P+ =  1 -  P- 
=  l  -  e -us. This equation thus defines the relationship predicted by the one-hit model between 
the concentration of EBV-containing supernatant used to stimulate the cultures and P÷, the 
probability of observing a  well containing Ig. 
A  similar approach was  used  to  derive the predicted relationship between the dilution of 
virus and the probability of observing an Ig-containing well based on an alternative hypothesis, 
that a  precursor B  cell must be infected by two or more EBV virions before it is activated to 
secrete Ig (two-hit model). In this case, the probability of any one precursor not producing Ig 
is given by the sum of probabilities that it is infected by zero or one virions; thus; p_ =  p0 +  pl 
=  e -u +  ue  -u. The probability that a  well with N  potential B cell precursors contains at least 
one precursor that is infected by two virions and is activated to produce Ig is then: P+ =  1 - 
p  N _  1 -- [e-UN'(1 +  u)N]. This formula thus defines the relationship between the dilution of 
virus and probability of observing an Ig-containing well based on the two-hit model. 
For each model, u  (the mean number of infecting viral particles per B cell) can be expressed 
as Lxi/N, where xi is the dilution of the viral preparation used and L  is the (unknown) number 
of stimulating virions in the undiluted viral preparation. The value of the parameter L for each 
of the  two  models  that  best  fit  the  experimental  data  was  estimated  by  the  minimum  X  2 
method. For the one-hit model, the program described above was used. For the two-hit model, 
the goodness of fit X  2 for each value of L could be determined by substituting the above formula 
for P+ into the standard formula for X  ~ yielding: 
I  (ri -- ni [e  -Lx~ (1  +  Lxi/N)N]} z 
X2 =  i=i  y~  ni'e-tX~'[1 +  Lxi/N]N'[1  -  e -tx~ (1 +  Lxi/N)N] ' 
where ni is the number of wells established for each dilution of B95-8 supernatant xi, and ri is 
the number of negative wells at that concentration. L was determined by an iterative procedure 
to minimize this expression. 
The  degree  of consistency  of the  results  with  the one-  and  two-hit  models could  thus  be 
determined using the goodness of fit statistic with I-1  degrees of freedom. In addition, if either 
of these  two  models  were  valid,  the  value  of  L  calculated  for  that  model  would  give  the 
estimated frequency of infectious virions in the undiluted supernatant. 
Results 
Specificity of the Assays  for IgG and IgM.  Studies  were  first undertaken  to  assess  the 
specificity of the ELISA  for IgG and  IgM  by testing the reactivity of purified human 
IgG and of purified human  IgA and IgM  myeloma  proteins in these assays. As shown 
in Fig.  1, neither IgA nor IgM  in concentrations  of up to 500 ng/ml  resulted in optical 
densities above that  background  when  tested in the ELISA  for IgG.  Likewise,  neither 
IgA nor IgG reacted  in the ELISA  for IgM.  Thus,  both  assays were specific  for their 
respective isotypes. 
Determination of B Cell Precursor Frequencies.  Studies  were  next  undertaken  to deter- YARCHOAN, TOSATO,  BLAESE,  SIMON,  AND  NELSON 
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FIo.  1.  Specificity  of the assays  used to  measure IgG  and  IgM.  (A)  ELISA for IgG.  Various 
concentrations of IgG (O), IgA (V), and IgM (0) were tested for their reactivity in the sandwich 
ELISA used to measure IgG as described in the text. The optical density at 405 nm was measured 
after 90 min incubation with p-nitrophenyl phosphate. (B) ELISA for IgM. Specificity of the ELISA 
used to measure IgM was tested in the same manner. 
TABLE  I 
Comparison of the Efficiency of IgM Production in EB V-stimulated 
Macrocultures and Microcultures * 
Number of B  IgM per 10  a added 
Culture condition  cells/culture  B cells 
ng 
Macrocuhures (106 TxR):~  105  36.4 (X/+ 1.18)§ 
Microcult  ures ( 10  ~ T xrt)  60  101 
120  62.3 
240  137 
480  108 
* Simultaneously established macrocultures and microcultures  were stimulated 
with EBV as described and the supernatants assayed for IgM. Macrocultures 
were in a total volume of 2.5 ml in 12-mm diam cluster tissue culture plates; 
microcultures were in  a  total  volume of 0.25-m1 in  96-well  flat-bottomed 
microculture  plates.  For  each  dose  of B  cells  in  the  microcultures,  the 
supernatants of 24 replicate wells were pooled before being assayed. 
T cells irradiated with 1,200 rad. 
§ Geometric mean (×/+ SEM) of four replicate macrocultures. 
mine the frequencies of peripheral blood B  cells that could be activated by EBV  to 
produce IgM or IgG. Before doing so, however, it was necessary to determine whether 
the efficiency of Ig production  in the microculture system used in these experiments 
was equivalent to that  in more conventional "macrocultures." As shown in Table  I, 
the mean IgM production per added B cell in multiple microcuhures, each containing EPSTEIN-BARR  VIRUS-INDUCED  IMMUNOGLOBULIN  PRODUCTION 
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Ftc.  2.  Limiting dilution analysis to determine the precursor frequencies oflgM- and IgG+secreting 
cells in EBV-stimulated cultures. 36 replicate EBV-stimulated  microcultures were established with 
each of various numbers of B cells and l0  b irradiated (1,200 rad) T cells. After 14 d in culture, the 
supernatants  were harvested and assayed for IgM and IgG. The fraction of cultures  negative for 
IgM (©) and for IgG (0)  were plotted against  the number  of added B cells as shown and the 
precursor frequencies of IgM- and IgG-secreting cells were calculated as described in the text. In 
this experiment,  1 in 58 added B cells produced IgM and 1 in 281 produced IgG. The stippled areas 
denote the 95% confidence intervals. 
a  limited number of B  cells and  105  irradiated T  cells, was equal to or greater than 
that  produced  in  macrocultures  containing  105  B  cells and  106  irradiated T  cells. 
Thus,  microcultures could be used to study the activation of B  cells by EBV,  as the 
Ig produced per B  cell was at least as efficient as in macrocultures. 
A  number  of experiments  were  next  undertaken  to  determine  the  precursor  fre- 
quency of B cells that were activated by EBV to produce IgM or IgG. A representative 
experiment is shown in Fig. 2. As can be seen, the plot of B cell number vs. the log of 
the frequency of negative cultures yielded a  straight line both for IgM- and for IgG- 
producing cells. This suggested that:  (a) the ELISA used enabled the detection of the 
Ig secreted by the progeny of a  single precursor B  cell, and  (b) that one cell type was 
limiting in these cultures. If either of these conditions were not met, the plots would 
yield lines that curved downward (23). The minimum X  2 method was used to estimate 
the  precursor frequencies;  in  this  experiment,  1 in  58  added B  cells produced  IgM 
(1:49-1:71, 95% confidence interval) and  1 in 281  added B cells produced IgG (1:224- 
1:374, 95% confidence interval). 
The  results  obtained  in  a  number  of such  experiments  are  shown  in  Table  II; 
precursor frequencies obtained in PWM-stimulated cultures are shown  for compari- 
son.  The  precursor  frequencies  for  EBV-induced  IgM-producing  cells varied  from 
1:50 to  1:220 B cells, and those for IgG-producing cells varied from ~  1  : 150 to  1:450 
B cells. It should be noted that any given precursor frequency determination represents 
a  minimum estimate for the "actual" precursor frequency; with more efficient culture 
conditions,  additional  B  cell  precursors  might  be  activated.  To  investigate  this 
possibility, several different culture conditions were tested including:  (a)  an  increase 
in  the  number  of irradiated  feeder T  cells,  (b)  culturing  in  U-bottomed  microtiter 
wells, and  (c) preinfecting the B  cells with EBV by incubating 2  ×  l0  G B  cells at 37 ° 
for 5 h  with 5 ml of highly concentrated virus (Table III). None of these approaches 
yielded a  significant increase in the observed precursor frequency. YARCHOAN, TOSATO, BLAESE,  SIMON,  AND NELSON 
TABLE  II 
Determination orB Cell Precursor Frequencies  for IgG and IgM Production in 
Cultures Stimulated with EBV or PWM* 
Experiment 
EBV  PWM 
IgM  IgG  IgM  IgG 
1  l:219:~  1:152  --  -- 
2  --  --  1:691  1:483 
3  1:142  1:420  l:222  l:172 
4  1:58  1:28l  1:766  -- 
5  1:164§  --  l:3,212  -- 
6  --  --  1:3,093  1:3,755 
* Precursor  frequencies for IgM- and tgG-secreting B cells were determined in 
cultures stimulated with EBV or PWM as described in the text. 
:~ Precursor  frequencies are expressed as a fraction of the B cell population. 
§ The total IgM secreted  into the cultures used  to determine this precursor 
frequency is shown in Table I. 
TABLE  III 
Determinations of the Precursor  Frequency  for EB V-induced IgM Production in a B Cell Preparation Using 
Different Culture Conditions* 
Determination  Number of irradiated  Geometry of microtiter  Precursor  frequency:~ 
number  T cells (1,200 tad)  wells 
1  1 ×  105  Flat-bottomed  1:502 (1:356-1:852) 
2  1.5 ×  105  Round-bottomed  1:629 (1:427-1 : 1,175) 
3  1.5 ×  105  Round-bottomed  1:314 (1 : 196- l :  786) 
* The precursor frequency for IgM-secreting B cells was simultaneously determined using the three culture 
conditions described.  All determinations were made using the same B cell preparation. For determinations 
1 and 2, preparation 2 of EBV (106 virions/ml) was added directly to the cultures at a final dilution of 
1:5. For determination  3,  1 ×  106  B cells were incubated  with 5 ml of preparation  3 of EBV  (>109 
virions/ml) for 5 h, appropriately diluted, and added to the cultures. 
:~ Results  in parentheses  are the 95% confidence intervals. 
By  simultaneously  determining  the  B  cell precursor  frequency  and  the  IgM  pro- 
duced per added B cell, an estimate of the IgM produced per EBV-activated precursor 
B  cell could be made. In Table II, experiment 5, for example, the precursor frequency 
of B  cells activated  by  EBV  to  produce  IgM  was  1:164  and  ~100  ng  of IgM  was 
produced  per  1,000  added  B  cells  (Table  I).  Thus,  in  this  experiment,  each  B  cell 
precursor  activated  with  EBV  produced  ~16  ng  of  IgM  during  the  14-d  culture 
period. 
Isotype Produced  by Individual  B  Cell Precursors.  Previous  studies  have  demonstrated 
that  IgG-, IgA-, and  IgM-secreting cells are detectable  in EBV-stimulated  cultures of 
peripheral  blood  mononuclear  cells  and  that  all  three  isotypes  are  produced  in  the 
absence of T  cells (10-12).  We next addressed  the question as to whether the progeny 
of one precursor B cell stimulated with EBV secreted both IgM and IgG Ig or whether 
only a  single isotype was secreted.  Multiple replicate microtiter wells were established 
with  105  irradiated  T  cells and  a  limited  number  of B  cells;  the  B  cell number  was 
selected  based  on  previous  precursor  frequency  determinations,  so  that  each  well 
contained  approximately  one-half  to  one  B  cell  precursor  for  IgM  per  well.  The 
cultures  were stimulated  with EBV and  the supernatant  of each well was assayed  for 
both  IgM  and  IgG.  The  number  of wells in  which  both  isotypes  were  detected  was EPSTEIN-BARR VIRUS-INDUCED  IMMUNOGLOBULIN  PRODUCTION 
TABLE  IV 
Number of Wells in which Both IgG and IgM Were  Produced, and Comparison with the Number Predicted 
by Chance Alone 
Number  Number of wells 
Stimu-  Experi-  of B  Total  Premcted  X  2  p§ 
lator  merit  cells*  wells  G-M-  G-M  +  G+M  -  G+M  +  G+M+~ 
EBV  1  60  324  130  139  26  29  28.5  0.00  >0.90 
2  6(t  36  I5  5  11  5  4.4  0.00  >0.90 
120  36  tO  4  12  10  8.6  0.44  >0.50 
5  60  288  124  110  28  26  25.5  0.00  >0.90 
PWM  3  480  288  138  45  64  41  31.4  5.99  <0,02 
4  240  48  12  9  20  7  9.0  0.86  >0.30 
480  48  i2  6  11  I9  15.6  2.94  >0.05 
5  240  288  28  62  61  137  136.8  0.01  >0.90 
* Number of B cells added to each welt. 
:~ Predicted number ofG+M + wells based on the total number ofG  + and M  + wells. 
§ Significance level for  the  discrepancy between the  observed results and those predicted under  the 
hypothesis that there are no precursors producing both IgM and IgG. 
compared  with  the  number predicted  by  chance  alone  if the  precursors  for  each 
isotype segregated independently. As shown in Table IV, in each of three experiments 
the number of wells with both IgM and IgG was consistent with that  predicted by 
chance alone (P >  0.05), and in most cases  the number was nearly identical. Thus, 
the  precursor  cells  whose  progeny produced  IgM  were  separate  from  those  whose 
progeny produced IgG; in other words, a cell stimulated with EBV could be induced 
to secrete IgM or IgG in short-term culture, but not both. 
Similar studies were undertaken in cultures stimulated with PWM  (Table IV). In 
all but one experiment, a  similar result was observed; the  precursors  for IgM were 
separate from those for IgG. In one experiment (experiment 3), however, there were 
slightly more  wells  in which  IgM  and  IgG were  detected  than  were  predicted  by 
chance alone (P <  0.02),  suggesting that  the  progeny of a  small percentage of the 
precursor B cells secreted both IgM and IgG. Even in this experiment, it is estimated 
that over 90% of the B cells stimulated by PWM produced only one isotype. 
Determination  of the Number of  Stimulating Virions.  It has previously been demonstrated 
that a single EBV particle is sufficient to "transform" an individual B cell into a long- 
term  B  cell  line (one-hit model)  (i3).  We addressed  the  question as  to  whether  Ig 
production, like B cell transformation by this virus, follows a  one-hit model. Because 
EBV is particulate, cell infection in culture with limiting numbers of virions should 
follow  a  Poisson  distribution; analysis of  Ig  production  in  multiple cultures  with 
limiting dilutions of EBV might thus enable the study of the viral requirements for B 
cell activation to Ig production. To this end, multiple replicate cultures were estab- 
lished with 105 B cells (surface Ig-positive and E-) and various dilutions of preparation 
1 of EBV.  After  14  d,  the supernatants were assayed  for IgM  and/or IgG and  the 
frequency of cultures positive for IgM and/or IgG was determined for each dilution 
of the EBV-containing supernatant. 
The  first  question  addressed  was  whether  the  results  were  consistent  with  the 
hypothesis that one infecting virion was sufficient to activate a  B cell to produce Ig 
(one-hit model) or alternatively, with the hypothesis that two or more infecting virions YARCHOAN,  TOSATO,  BLAESE,  SIMON,  AND  NELSON 
were required (two-hit model). As described in Materials and Methods, the predicted 
mathematical relationships between the mean number of infecting virions per B cell 
(u)  and  the  frequency of positive  cultures  can  be  derived  based  on  each  of these 
models.  The  curves showing these  theoretical  relationships  are  shown  in  Fig.  3 A. 
When plotted in this manner, both theoretical curves are sigmoid shaped. The two- 
hit curve is shifted to the left of the one-hit curve, as a greater mean number of viral 
particles per B cell are required to activate at least one B cell in any given fraction of 
cultures with the former (two-hit)  model. In addition, the slope of the central linear 
portion is steeper with the two-hit curve than with the one-hit curve; if more than two 
viruses are required  (three-hit,  etc.), then the central part of the curve is steeper yet 
(curves not shown). These differences in  slope can be used  to visually approximate 
which curve most closely fits the experimental results. 
Fig.  3 B  shows  the  experimental  results  obtained  in  a  typical  experiment  with 
limiting dilutions of virus in which IgM production was examined.  As can be seen, 
the slope of the plotted experimental results is closer to that of the one-hit curve than 
that of the two-hit curve, suggesting that infection by one EBV virion was sufficient 
to  induce  a  B  cell  to  produce  IgM.  To  analyze these  results  more  rigorously,  the 
minimum X  2 method was used to fit the experimental results obtained to both models 
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FIG.  3.  The activation of B cells by EBV is consistent with a one-hit model. (A) Theoretical curves 
of u  (the probability that any given precursor B cell  is infected by a  virion) vs. the probability of 
observing wells with secreted Ig calculated  for  103 precursor B cells  using the one-hit and two-hit 
models as described in the text. The two-hit curve has a  steeper central portion than the one-hit 
curve  when  plotted  in  this  manner.  (B)  Observed  results  in  cultures  established  with  limiting 
dilutions of EBV.  105 B cells  in a  final volume of 0.2  ml were stimulated with various dilutions of 
the supernatant of the B95-8  marmoset line,  and the fraction of wells in which IgM was detected 
was calculated for each dilution of virus. As can be observed, the shape of this curve is close to that 
predicted by the one-hit model. 10  EPSTEIN-BARR VIRUS INDUCED  IMMUNOGLOBULIN  PRODUCTION 
TABLE V 
Activation of B  Cells by EBV  to Produce Ig Is Consistent with a  One-Hit but not a  Two-Hit model* 
Replicates  One-hit model  Two-hit model 
Experi-  Ig class  per dilution  Activating virions/mI:~ 
ment  of virus  X  2  P  X  2  P 
1  IgM  20  4.04  >0.25  60.6  <0.005  7,100§  (4,880 9,300) 
IgG  20  4.63  >0.25  56.2  <0.005  11,260  (7,730-14,790) 
2  IgM  60  5.87  >0.10  108.3  <0.005  6,250  (5,030-7,490) 
* Multiple replicate cultures were established with 105 B cells and limiting dilutions of virus as described 
in the text. After 14 d in culture, the wells were assayed for the presence of IgM and/or IgG, and the 
minimum X 2 method used to determine if these results were consistent with either the one- or two-hit 
model. P is the probability value as measure of the goodness of fit with the model tested. 
:~ Estimate of the number of EBV virions per ml of undiluted supernatant as described in the text, based 
on the one-hit model. Numbers in parentheses are the 95% confidence interval. 
§ The results of this experiment are also shown plotted in Fig. 3. 
one-hit model but not the two-hit model. 
Having shown  that  the  activation of B  cells by EBV  to  produce  IgM  or  IgG is 
consistent  with  the  distribution predicted  by  a  one-hit  model,  it  was  possible  to 
determine the concentration of stimulating EBV virions detectable in the supernatant 
of the B95-8 marmoset line used as a  source of EBV.  As shown in Table V, under 
these culture conditions, there were ~ 104 stimulating EBV virions detectable per ml 
of supernatant; similar results  were  obtained whether  IgM  or  IgG  activation was 
examined. These results were also in agreement with the determination of cord blood- 
transforming units in this preparation of virus (104 per ml). 
Discussion 
The results presented here demonstrate that only a small fraction of the circulating 
human B lymphocytes can be activated by EBV in vitro to secrete IgM or IgG. Thus, 
whereas almost all human B  lymphocytes are believed to express receptors for EBV 
(6), only 0.2-1% are activated by EBV to Ig secretion. 
Previous studies have attempted to determine the frequencies of B cells manifesting 
other features of infection by EBV.  Henderson et  al.  (13)  have estimated that up to 
10%  of T-depleted  cord  blood  cells  are  transformed  by  the  virus;  this  estimation 
involved a  20-fold correction for the inefficiency of their plating system. Bird et  al. 
(27)  have reported that  10-30% of B cells express EBNA, the EBV-encoded nuclear 
antigen,  3  d  after  in  vitro  infection  with  EBV.  The  0.2-1%  frequency  of  cells 
stimulated by  EBV  to  secrete  Ig observed here  is somewhat  lower  than  the  values 
reported for these other two features of infection. Although this determination must 
be  considered  a  lower  limit  for  the  precursor  frequency, attempts  to  increase  the 
observed number of precursors by altering the culture conditions or using a  highly 
concentrated  preparation  of  virus  failed  to  yield  significantly different  results.  It 
should be noted, however, that these precursor frequencies are for cells secreting Ig; 
it is possible that the frequency of cells stimulated by EBV to produce cytoplasmic Ig 
might be higher. 
No  isotype  switching of secreted  Ig  was  detectable  when  EBV  was  used  as  the 
culture stimulant; precursor cells secreted either IgM or IgG, but  not both.  This is 
unlikely to  be an artifact  of the  assay or culture system, as  most  artifacts  in these 
determinations  (i.e.,  B  cell  clumping, cross-reactivity  in  the  assay,  plate-to-plate YARCHOAN, TOSATO, BLAESE, SIMON, AND NELSON  11 
variation in the ELISA) would lead to an overestimation of isotype switching.  The 
failure  to  observe isotype switching  in  these  short-term  cultures  is  consistent  with 
studies of Brown and Miller (28)  who reported that almost all B cell clones obtained 
by EBV transformation of adult peripheral blood mononuclear cells secreted only one 
isotype; the few clones that appeared to secrete more than one isotype in their study 
could have been in reality admixtures of more than one clone. Combining their study 
with  the  present  one,  the  Ig secreted  by  the  progeny  of any  given  EBV-infected 
peripheral  blood  B  cell  is  almost  always  restricted  to  one  isotype.  Thus,  isotype 
switching is not an inevitable consequence of continued B cell proliferation. 
The  lack  of isotype  switching  observed  here  with  EBV  contrasts  with  reported 
studies of murine B cells. Using a similar limiting dilution technique, Anderson et al. 
(29)  found that all of the IgG-secreting cells in lipopolysaccharide (LPS)-stimulated 
cultures  of murine  spleen  cells  developed  by  isotype switching  in  clones  that  had 
previously contained  IgM-secreting cells;  similar  results  have been  obtained  using 
cells obtained  from a  variety of murine  lymphoid  organs  (30).  Other  investigators 
have  reported  the  frequent  detection  of  isotype  switching  in  antigen-stimulated 
cultures of murine B cells using the splenic focus technique  (31,  32). Several possible 
explanations can be considered for the lack of isotype switching observed here; these 
include (a) an intrinsic difference between human and murine B cells, (b) a difference 
between peripheral blood B cells and those of other lymphoid organs, or (c) that lack 
of isotype switching  is  a  feature of stimulation  by EBV.  Whereas  LPS  is  generally 
considered to be a T  cell-independent B cell activator, previous studies have revealed 
that the IgG and IgA production induced  by LPS is increased by the presence of T 
cells (33, 34).  In contrast, T  cells do not affect the relative proportion of the isotypes 
secreted in EBV-stimulated cultures of human peripheral B cells (10,  12). It was thus 
possible that  isotype switching would only be induced  when T  cell-dependent  or T 
cell-enhanced  B  cell activators were utilized.  To investigate this hypothesis,  PWM- 
stimulated  cultures  were  examined.  Using  this  T  cell-dependent  B  cell  polyclonal 
activator, however, no isotype switching was observed except possibly in one experi- 
ment. Even in this experiment, where more wells containing both IgG and IgM were 
observed than were predicted  (Table IV, experiment 3), it was possible that this was 
an  artifact  due  to  B  cell clumping  or to  intra-experiment  variation  in  the  culture 
conditions. In similar PWM-stimulated studies using 60 replicate wells per experiment, 
Stevens  et  al.  (35)  did  not  observe  more  wells  containing  multiple  isotypes  than 
predicted  by chance alone.  Thus,  while  there  may be at  times a  low frequency of 
isotype switching  in  PWM-stimulated  cultures  of human  peripheral  blood  B  cells, 
most of the individual B cell precursors stimulated with this T cell-dependent activator 
secrete only a single class of Ig. 
It is believed that stimulation of B cells to secrete Ig by the B95-8 strain of EBV 
occurs through infection of these B cells by the virus (27). With this background, we 
used  a  limiting  dilutions  of virus  to  investigate  the  viral  requirements  for  B  cell 
activation  by  EBV.  These  studies  demonstrated  that  the  activation  of B  cells  to 
produce either IgM or IgG was consistent with a  one-hit  model and thus allowed a 
determination  of the titer of infectious virions in the B95-8 supernatant  used.  It has 
been proposed that determinations of this sort may be affected by variations in the 
ability  of different  cells  to  be  infected  by  a  given  virus  (36).  With  the  present 
experimental design,  however, in which  only one Ig-producing B  cell precursor per 12  EPSTEIN-BARR  VIRUS-INDUCED  IMMUNOGLOBULIN  PRODUCTION 
culture is required for detection, this effect should be minimal. 
Transformation of umbilical cord B cells  by EBV has previously (13) been shown 
to also follow a one-hit model using a similar approach. In addition, these results are 
consistent with the findings of Byrd et al. (27), who demonstrated that the number of 
IgM-secreting plaques in EBV-stimulated cultures was proportional to the dilution of 
the virus. Taken together, these studies indicate that infection of a B cell by one viral 
particle is sufficient to induce that cell to secrete Ig and/or to immortalize that cell. 
It is not clear, however, what the relationship is between these two outcomes of B cell 
infection by EBV and in particular, whether all cells activated by EBV to produce Ig 
are also transformed (37). 
In conclusion, limiting dilution techniques provide a powerful tool for the study of 
the  individual  cellular  events  occurring  in  short-term  cultures  of lymphoid  cells. 
Further studies using this method should allow" an investigation of the precursors of 
B cells committed to the production of specific antibody, of other possible mediators 
of isotype switching, and  finally of the relationship between  EBV-induced transfor- 
mation and Ig production. 
Summary 
The  Epstein-Barr  virus  (EBV)  is  a  herpes  virus  that  has  the  capacity to  infect 
human  B ceils  and  to induce them  to secrete  immunoglobulin  (Ig).  In the current 
experiments, Poisson analysis of limiting dilution cultures has been used to study the 
activation of human peripheral B cells by the B95-8 strain of EBV. Under the culture 
conditions used, 0.2-1% of peripheral blood B cells were activated by EBV to secrete 
IgM or IgG, In addition, when multiple replicate cultures containing limited numbers 
of B cells were tested for IgM and for IgG production, the precursors for IgM and IgG 
segregated  independently;  thus,  individual  B  cell  precursors  matured  into  cells 
secreting IgM or IgG but not both classes of Ig. Additional experiments using limiting 
dilutions of EBV were undertaken to study the viral requirements for B cell activation. 
These studies  indicated that  B cell activation by EBV to produce Ig was consistent 
with  a  "one-hit"  model  and  inconsistent  with  a  "two-hit"  model.  Taken  together, 
these  results  indicate  that  infection  by  one  EBV  virion  is  sufficient  to  induce  a 
precursor peripheral blood B cell to secrete Ig and that only one isotype of Ig is then 
secreted. 
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